9999999995-22-001425.txt : 20220513 9999999995-22-001425.hdr.sgml : 20220513 20220513001812 ACCESSION NUMBER: 9999999995-22-001425 CONFORMED SUBMISSION TYPE: EFFECT PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20220512 DATE AS OF CHANGE: 20220513 EFFECTIVENESS DATE: 20220512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NANOMIX Corp CENTRAL INDEX KEY: 0001473579 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 270801073 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: EFFECT SEC ACT: 1933 Act SEC FILE NUMBER: 333-260298 FILM NUMBER: 22920059 BUSINESS ADDRESS: STREET 1: 354 MERRIMACK STREET STREET 2: #4 CITY: LAWRENCE STATE: MA ZIP: 01843 BUSINESS PHONE: (603) 935-9799 MAIL ADDRESS: STREET 1: 354 MERRIMACK STREET STREET 2: #4 CITY: LAWRENCE STATE: MA ZIP: 01843 FORMER COMPANY: FORMER CONFORMED NAME: Boston Therapeutics, Inc. DATE OF NAME CHANGE: 20101123 FORMER COMPANY: FORMER CONFORMED NAME: AVANYX Therapeutics, Inc. DATE OF NAME CHANGE: 20091001 EFFECT 1 primary_doc.xml X0101 EFFECT 33 LIVE 2022-05-12 16:00:00

S-1

0001473579 NANOMIX Corp 333-260298